Huaier Polysaccharide Interrupts PRV Infection via Reducing Virus Adsorption and Entry

Viruses. 2022 Apr 1;14(4):745. doi: 10.3390/v14040745.

Abstract

A pseudorabies virus (PRV) novel virulent variant outbreak occurred in China in 2011. However, little is known about PRV prevention and treatment. Huaier polysaccharide has been used to treat some solid cancers, although its antiviral activity has not been reported. Our study confirmed that the polysaccharide can effectively inhibit infection of PRV XJ5 in PK15 cells. It acted in a dose-dependent manner when blocking virus adsorption and entry into PK15 cells. Moreover, it suppressed PRV replication in PK15 cells. In addition, the results suggest that Huaier polysaccharide plays a role in treating PRV XJ5 infection by directly inactivating PRV XJ5. In conclusion, Huaier polysaccharide might be a novel therapeutic agent for preventing and controlling PRV infection.

Keywords: Huaier polysaccharide; antiviral; infection; pseudorabies virus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adsorption
  • Animals
  • Cell Line
  • Complex Mixtures
  • Herpesvirus 1, Suid*
  • Polysaccharides / pharmacology
  • Pseudorabies*
  • Trametes
  • Viruses, Unclassified*

Substances

  • Complex Mixtures
  • Polysaccharides
  • huaier